Key Highlights

  • USD 105 billion is the record backlog Northrop Grumman (NYSE:NOC) reported after the second quarter, up from USD 96 billion in the first quarter on about USD 20 billion of new awards, according to published earnings data.
  • USD 7.68 was second quarter earnings per share for Northrop Grumman (NYSE:NOC) against a consensus of about USD 6.82, on sales of USD 10.88 billion. Management then raised full-year guidance, including earnings per share by USD 1.20.
  • USD 7.18 to 7.22 is the published third quarter earnings consensus for Northrop Grumman (NYSE:NOC), on revenue of about USD 11.1 billion. The company reports before the market opens on Tuesday, October 20, 2026.
  • USD 1.85 billion is the 2026 capital spending outlook, which management has flagged as a possible drag on free cash flow, while cost adjustments hit the GEM 63XL and Stand-in Attack Weapon programs in the second quarter.

What the Setup Looks Like

Northrop Grumman (NYSE:NOC) will release third quarter results before the market opens on Tuesday, October 20, 2026, with a live audio webcast at 9:30 a.m. ET. Published consensus sits at about USD 7.18 to 7.22 per share and roughly USD 11.1 billion of revenue. The second quarter report on July 21, 2026 beat both lines, yet the shares still slipped in the event window, a reminder that a beat alone does not guarantee a rally.

Backlog, Guidance and Mechanism

Backlog is signed work not yet recognised as sales, so a record USD 105 billion gives revenue visibility rather than immediate profit. Orders were tied to Sentinel, B-21, missile programs and international contracts. Management raised full-year sales guidance to a midpoint of USD 44 billion and lifted earnings guidance by USD 1.20. Capital spending of USD 1.85 billion is a deliberate investment in capacity, but it competes with cash returned to shareholders.

Risks to Watch

Fixed-price development work is the main risk. An estimate-at-completion adjustment raises the expected cost of a contract and can reduce profit immediately, which happened on the GEM 63XL and Stand-in Attack Weapon programs in the second quarter. Management expects improvement in the second half, so any repeat charge would matter. Published data shows the stock near USD 499.63, below an earnings-anchored average of about USD 523, a gap that leaves less room for disappointment on margins or cash flow.

Where Things Stand

It can, but it is not assured. Northrop Grumman (NYSE:NOC) enters October 20, 2026 with a record backlog of USD 105 billion, a raised outlook and a history of beating consensus, which supports a third quarter beat on revenue near USD 11.1 billion. The balance of evidence is tempered by program cost adjustments, heavy capital spending and a share price that fell after the last beat. The next catalyst is the 9:30 a.m. ET webcast, where any update to full-year guidance, free cash flow and the second half margin recovery will carry more weight than the quarter itself.